News Statera Biopharma Receives Notification Letter from Nasdaq Regarding Form 10-K Filing Staff April 23, 2022 Iframe sync Post navigation Previous: The COVID-19 Respiratory Roundtable Issues Joint Letter Urging Canadians to Continue Protecting Each OtherNext: XVIVO Presents Interim Report January-March 2022 More Stories Healthcare News Robotics Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed Staff December 19, 2025 News Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase Staff December 19, 2025 Cancer News Pharmaceutical IMG Saxony-Anhalt: 2026 in Sight – Saxony-Anhalt Sets the Pace for Future Industries Staff December 19, 2025
